SLU-PP-332

What is SLU-PP-332?

SLU-PP-332 is a synthetic small molecule and pan-ERR (estrogen-related receptor) agonist, classified as an oral metabolic modulator in this 1000 mcg/tab, 100-tab pack from Dragon Pharma. Developed to mimic exercise effects, it's used in bodybuilding for fat loss and endurance. It has minimal hepatotoxicity, no aromatization, and limited side effects based on preclinical data, but it's investigational and requires medical oversight.

Mechanism of Action SLU-PP-332

SLU-PP-332 activates ERRα, ERRβ, and ERRγ, upregulating genes like PGC-1α, GLUT4, and fatty acid oxidation enzymes, mimicking aerobic exercise. It enhances mitochondrial biogenesis, increases ATP production, and boosts fat metabolism, leading to improved endurance and reduced fat mass. Users notice fat loss and endurance improvements within 1-2 weeks when paired with a calorie-deficit diet.

With a half-life of approximately 1.5 hours, SLU-PP-332 requires multiple daily doses (2-3 times) for stable effects. It doesn't affect hormonal pathways, ensuring no endocrine disruption. What doesn't happen: no testosterone or estrogen impact, no water retention, and minimal liver toxicity, but metabolic monitoring is advised.

Mild side effects like sweating or headaches may occur, manageable with proper dosing.

How It Works & Key Benefits

SLU-PP-332 excels for bodybuilders in cutting cycles, requiring a calorie-deficit diet and cardio to maximize its exercise-mimetic benefits.

• Promotes fat loss (5-12% weight loss in preclinical studies).
• Boosts endurance and running capacity.
• Enhances mitochondrial function and ATP production.
• Improves insulin sensitivity for metabolic health.
• Supports lean physique goals without hormonal interference.
• Stacks well with other fat-loss agents.

Who It's For & Product Specifications

Best for intermediate to advanced bodybuilders aged 21-40 seeking fat loss and endurance in cutting cycles; suitable for men and women. Not recommended for those under 21, with metabolic disorders, or without medical supervision.

How to Use

1. Dosage: 100-500 mcg/day, split into 2-3 doses (e.g., 50-250 mcg per dose); start at 100 mcg to assess tolerance.
2. Frequency: Daily, taken with water, preferably before cardio or fasted workouts.
3. Cycle length: 4-8 weeks, followed by 2-4 week break to assess progress.
4. Preparation/Monitoring tips: Monitor glucose and lipids via labs; maintain a calorie-deficit, high-protein diet; pair with cardio for optimal fat loss.
5. Results timeline: Fat loss and endurance improvements in 1-2 weeks; significant body composition changes in 4-8 weeks.
6. PCT timing: Not required as SLU-PP-332 doesn't suppress hormones; align with steroid stack's PCT if combined (e.g., 3-4 days post-short ester).

Popular Stacks

Cardarine: Enhances fat loss and endurance synergy.

L-Carnitine: Boosts fat oxidation for complementary effects.

CoQ10: Supports mitochondrial function and energy.

Cycle Support: Enhances metabolic health during protocols.

Comparisons & Alternatives

SLU-PP-332 vs Cardarine: SLU-PP-332 mimics exercise via ERR activation; Cardarine targets PPARδ for endurance and fat loss.

SLU-PP-332 vs GW 501516: SLU-PP-332 focuses on mitochondrial biogenesis; GW 501516 emphasizes lipid metabolism.

SLU-PP-332 vs Clenbuterol: SLU-PP-332 is non-stimulant with sustained effects; Clenbuterol provides rapid thermogenesis with stimulant risks.

Side Effects & Risk Management

• Systemic: Mild sweating, hot flashes—stay hydrated, adjust dose.
• Gastrointestinal: Rare nausea—take with food if needed.
• Neurological: Mild headaches, anxiety—monitor, reduce dose if occurs.
• Hepatic: Minimal impact—routine liver tests advised.
• Endocrine: None; no hormonal disruption.

Review labs with a professional where lawful to ensure authenticity and safe dosing. SLU-PP-332 is investigational and not FDA-approved for human use, sold for research purposes only.

Post-Cycle Therapy (PCT)

SLU-PP-332 requires no PCT as it doesn't suppress testosterone or HPTA; align with steroid stack's PCT if combined (e.g., 3-4 days post-short ester). Use tamoxifen or clomiphene for 4 weeks if needed, guided by bloodwork.